Published in Medical Devices and Surgical Technology Week, November 27th, 2005
The incremental impact of foreign currency on sales for the third quarter of 2005 was a positive $0.2 million or 0.3%.
Net income for the third quarter was $46.0 million, or $2.81 per diluted share, compared with $8.4 million, or $0.53 per diluted share, for the same period in 2004. Net income for the third quarter included a gain of $38.2 million or $2.33 per diluted share, net of related costs and taxes,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.